Why It Matters
Johnson & Johnson registered Forbes Tate Partners LLC as a lobbying firm on Aug. 14, marking a shift in the company's government relations strategy. The pharmaceutical and healthcare giant will now lobby on health issues and Medicare/Medicaid matters through the firm.
Forbes Tate Partners LLC assigned three lobbyists to the account: Libby Greer, Michael Williams, and Cindy Brown, all partners at the firm. Greer previously served as Chief of Staff to Rep. Allen Boyd (D-FL-2) and spent roughly eight years in Congress. Williams has prior congressional experience with both Sen. Doug Jones (D-AL) and Rep. Lucy McBath (D-GA-6). Brown served as D.C. Chief of Staff to Rep. Ron Kind (D-WI-3) and spent approximately nine years in Congress.
Broader Context
Medicare payment rates, drug pricing mechanisms, and coverage policies continue to draw industry attention on Capitol Hill. J&J's lobbying registration comes as Congress addresses various healthcare-related issues, though the specific legislative targets were not listed in the filing.
Eli Lilly & Co. maintains an active lobbying operation through Forbes Tate Partners. Eli Lilly & Co. and Amgen Inc. both have representation through the firm, with the latter paying $290,000 in lobbying fees. The firm's healthcare practice extends beyond pharmaceuticals to include medical device makers and healthcare service providers.
Spot something wrong? Report an issue with this article